在怀孕期间和怀孕后,在患有的妇女中,拉莫特里金性质的变化
Ashwin Karanam1,2, Page B Pennell3, Kimford J Meador4
1Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Pharmacotherapy
|January 7, 2025
概括
大多数患有的孕妇 (PWWE) 经历了显著的lamotrigine清除变化,但有一小部分没有. 在PWWE中,拉莫特里金的药理动力学有所不同,这会影响怀孕期间和之后的剂量调整.
科学领域:
- 药理动力学 药理动力学
- 症管理 症管理
- 怀孕和药物新陈代谢 怀孕和药物新陈代谢
背景情况:
- 在患有的孕妇 (PWWE) 中,拉莫素清除量的变化使剂量复杂化.
- 在怀孕和产后期间了解PWWE中lamotrigine的药理动力学至关重要.
研究的目的:
- 在整个怀孕和产后期间,在PWWE中描述拉莫特里金的药理动力学.
- 为了比较PWWE和患有的非孕妇 (NPWWE) 之间的lamotrigine药理动力学.
主要方法:
- 美国20个地点 (2012-2016) 的前性观察队列研究 (MONEAD).
- 包括170名PWWE和51名NPWWE年龄在14-45岁之间,接受了lamotrigine.
- 人口混合效应建模用于分析lamotrigine清除变化,在七次访问中测量了血药物和激素水平.
主要成果:
- 在PWWE和NPWWE (2.79 L/小时) 之间,基线拉莫特里金清除值相似.
- 确定了PWWE的两个亚群:约91%的孕期清除增加了275%,而约9%的清除变化很小.
- 通过单指数下降,拉莫特里金清除恢复到产后基线;以雌激素为基础的药物和诱导酶的抗发作药物增加了非孕妇清除.
结论:
- 大约91%的PWWE在怀孕期间表现出显著的lamotrigine清除变化,需要调整剂量.
- 一个明显的PWWE亚群 (~9%) 显示出最小的清除变化,可能避免实质性的剂量修改.
- 含有雌激素的药物与PWWE和NPWWE的非孕妇拉莫特里金清除率较高有关.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
240
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
240
Antiepileptic Drugs: Glutamate Antagonists
279
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
279
Antiepileptic Drugs: GABAergic Pathway Potentiators
321
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
321
Mania and Antimanic Drugs: Overview
127
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
127
Antiepileptic Drugs: Sodium Channel Blockers
402
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
402


